Follow-The-Filings

Congress trades

ORMP Oramed Pharmaceuticals Inc.

Members of Congress who traded or hold Oramed Pharmaceuticals Inc., from their STOCK Act disclosures. None of the featured 13F managers hold it, so this page covers Congress only. ORMP earnings.

  • 1 members traded it since Oct 4, 2023
  • 0 / 1 buys / sales
  • 1 held it at year end (2025)
  • Jan 10, 2025 latest trade

Who holds it

Each member's latest annual report · value at year end, in the range disclosed

  1. Brad Knott R-NC-13Self · 2025 $15K–$50K

Trades

1 trade since Oct 4, 2023 · newest filings first

  1. Brad KnottR-NC-13House
    ORMPOramed Pharmaceuticals Inc.
    Sell
    $15K–$50K
    Traded Jan 10, 2025Filed Feb 25, 2025 46d
    ↗

Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. All Congress trades · How we read these reports.